This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Sarah Arden
Team Lead (Acting), New Technologies and Innovation Group: Manufacturing, Methods Development, Modeling/Simulations Science and Research Staff at Office of Pharmaceutical Quality (OPQ)/Center for Drug Evaluation and Research (CDER)


Dr. Arden leads the New Technologies and Innovation group in the Office of Pharmaceutical Quality CDER/FDA, focusing on advanced manufacturing, methods and modeling. She previously served as a CMC reviewer in the Office of Biotechnology Products. Dr. Arden received her Ph.D. in Chemical and Biomolecular Engineering from Johns Hopkins University and B.S. from the University of California, San Diego. She completed postdoctoral studies at ETH Zurich and Stanford University. Prior to joining FDA, Dr. Arden co-founded a digital health technology startup and worked as a technology advisor to industry and government clients.